Registration for a live webinar on 'Gamma-delta T cells for immunotherapy of cancer' is now open.See webinar details
Dr. W. Marston Linehan National Institutes of Health, USA1 Talk
W. Marston Linehan, M.D. is Chief of Urologic Surgery and the Urologic Oncology Branch, Center for Cancer Research, at the National Cancer Institute, National Institutes of Health, Bethesda, Maryland. He received his internship, residency and fellowship training at Duke University Medical Center and then began his career at the National... read moreCancer Institute in 1982.
He has had a long standing interest in identification of the genetic basis of cancer of the kidney. By studying patients and families with kidney cancer, he and his colleagues have identified the genes involved in many different types of renal carcinoma, as well as describing five new diseases. This work has provided the basis for the development of new therapeutic strategies for the different types of kidney cancer based on understanding the molecular pathway of the specific cancer genes associated with the different types of kidney cancer.
Dr. Linehan is a member of the Institute of Medicine of the National Academy of Science and is or has been on the editorial board of 14 journals. He has received the Joseph H. Burchenal Memorial Award for Outstanding Achievement in Clinical Cancer Research from the American Association of Cancer Research, the Dr. Nathan Davis Award from the American Medical Association, the Lila Gruber Award for Cancer Research from the American Association of Dermatology, the NIH Director’s Award for discovery of the VHL kidney cancer gene, the Barringer Medal from the American Association of Genitourinary Surgeons, the Gold Cystoscope Award and the Distinguished Contribution Award from the American Urological Association, the Huggins Medal and the SUO Medal from the Society of Urologic Oncology and the Andrew C. Novick Award from the Kidney Cancer Association.